JN: "The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] NLMUID: 7513617" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
Autorzy :: Fifer H; National Infection Service, Public Health England, London NW9 5EQ, UK.
Livermore DM; Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
Uthayakumaran T; National Infection Service, Public Health England, London NW9 5EQ, UK.
Woodford N; National Infection Service, Public Health England, London NW9 5EQ, UK.
Cole MJ; National Infection Service, Public Health England, London NW9 5EQ, UK.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 20. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
Autorzy :: Mason CY; Department of Infection, Royal Free London NHS Trust, London, UK.
Kanitkar T; Department of Infection, Royal Free London NHS Trust, London, UK.
Richardson CJ; Department of Infection, Royal Free London NHS Trust, London, UK.
Lanzman M; Department of Pharmacy, Royal Free London NHS Trust, London, UK.
Stone Z; Department of Pharmacy, Royal Free London NHS Trust, London, UK.
Mahungu T; Department of Infection, Royal Free London NHS Trust, London, UK.
Mack D; Department of Infection, Royal Free London NHS Trust, London, UK.
Wey EQ; Department of Infection, Royal Free London NHS Trust, London, UK.; Division of Infection & Immunity, University College London, London, UK.
Lamb L; Department of Infection, Royal Free London NHS Trust, London, UK.; Academic Department of Defence Medicine, Royal Centre for Defence Medicine, Birmingham, UK.
Balakrishnan I; Department of Infection, Royal Free London NHS Trust, London, UK.
Pollara G; Department of Infection, Royal Free London NHS Trust, London, UK.; Division of Infection & Immunity, University College London, London, UK.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Is short-term antibiotic therapy safe in patients with central venous catheter-related Gram-negative bacteraemia?
Autorzy :: Lee YM; Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
Moon C; Department of Infectious Diseases, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Park KH; Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Republic of Korea.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 539-541.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
Autorzy :: Hernández-García M; Servicio de Microbiología, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, Spain.
García-Castillo M; Servicio de Microbiología, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, Spain.
García-Fernández S; Servicio de Microbiología, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, Spain.
Melo-Cristino J; Serviço de Microbiologia Centro Hospitalar Lisboa Norte, Lisboa, Portugal.
Pinto MF; Laboratório de Microbiologia, Serviço de Patologia Clínica, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal.
Gonçalves E; Laboratório de Microbiologia Clínica Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal.
Alves V; Laboratório de Microbiologia, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.
Vieira AR; Serviço de Patologia Clínica, Centro Hospitalar Universitário São João, Porto, Portugal.
Ramalheira E; Serviço Patologia Clínica, Hospital Infante Dom Pedro, Aveiro, Portugal.
Sancho L; Serviço de Patologia Clínica, Hospital Prof. Dr. Fernando da Fonseca, Amadora, Portugal.
Diogo J; Serviço de Microbiologia, Hospital Garcia de Orta, Almada, Portugal.
Ferreira R; Serviço de Patologia Clínica-Microbiologia-CHUA-Unidade de Portimão, Portimão, Portugal.
Silva T; Serviço de Microbiologia do Centro Hospitalar Universitário do Porto, Porto, Portugal.
Chaves C; Serviço de Microbiologia, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
Bou G; Servicio de Microbiología, Hospital Universitario A Coruña, A Coruña, Spain.
Cercenado E; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Delgado-Valverde M; UGC Enfermedades Infecciosas, Microbiología Clínica y Medicina Preventiva, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, Sevilla, Spain.
Oliver A; Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
Pitart C; Servicio de Microbiología, Hospital Clínic i Provincial, Barcelona, Spain.
Rodríguez-Lozano J; Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Tormo N; Servicio de Microbiología, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Romano J; MSD Portugal, Paço de Arcos, Portugal.
Pássaro L; MSD Portugal, Paço de Arcos, Portugal.
Paixão L; MSD Portugal, Paço de Arcos, Portugal.
López-Mendoza D; Departamento Médico, MSD España, Madrid, Spain.
Díaz-Regañón J; Departamento Médico, MSD España, Madrid, Spain.
Cantón R; Servicio de Microbiología, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, Spain.; Pokaż więcej
Corporate Authors :: STEP and SUPERIOR study groups
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 370-379.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: The success of particular Acinetobacter baumannii clones: accumulating resistance and virulence inside a sugary shield.
Autorzy :: Silva L; UCIBIO/REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.; ESALD, Instituto Politécnico de Castelo Branco, Castelo Branco, Portugal.
Grosso F; UCIBIO/REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
Rodrigues C; UCIBIO/REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
Ksiezarek M; UCIBIO/REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
Ramos H; Hospital Geral de Santo António (HGSA), Porto, Portugal.
Peixe L; UCIBIO/REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 305-311.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
Autorzy :: Shropshire WC; Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA.; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Aitken SL; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.; Division of Pharmacy, MD Anderson Cancer Center, Houston, TX 77030, USA.
Pifer R; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, McGovern Medical School at Houston, Houston, TX 77030, USA.
Kim J; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Bhatti MM; Department of Laboratory Medicine, MD Anderson Cancer Center, Houston, TX 77030, USA.
Li X; Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX 77030, USA.
Kalia A; Graduate Program in Diagnostic Genetics, School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Galloway-Peña J; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.; Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX 77030, USA.
Sahasrabhojane P; Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX 77030, USA.
Arias CA; Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA.; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.; Department of Microbiology and Molecular Genetics, University of Texas McGovern Medical School at Houston, Houston, TX 77030, USA.; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Ak. 9#131a2, Colombia.
Greenberg DE; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.; Department of Internal Medicine, UT Southwestern, Dallas, TX 75390, USA.; Department of Microbiology, UT Southwestern, Dallas, TX 75390, USA.
Hanson BM; Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA.; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Shelburne SA; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.; Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX 77030, USA.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 385-395.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan.
Autorzy :: Hayajneh WA; Department of Paediatrics and Neonatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Al-Azzam S; Clinical Pharmacy Department, Jordan University of Science and Technology, Irbid, Jordan.
Yusef D; Department of Paediatrics and Neonatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Lattyak WJ; Scientific Computing Associates Corp., River Forest, IL, USA.
Lattyak EA; Scientific Computing Associates Corp., River Forest, IL, USA.
Gould I; Medical Microbiology Department, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
López-Lozano JM; Research Group on Health Sciences Data Analysis, Universidad de Murcia, Murcia, Spain.
Conway BR; Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.; Institute of Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield, UK.
Conlon-Bingham G; Pharmacy Department, Craigavon Area Hospital, Craigavon, Northern Ireland, UK.
Aldeyab MA; Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 524-530.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage.
Autorzy :: Shen T; Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, USA.
Penewit K; Department of Laboratory Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Waalkes A; Department of Laboratory Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Xu L; Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, USA.
Salipante SJ; Department of Laboratory Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Nath A; Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, USA.
Werth BJ; Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, USA.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 292-296.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
Autorzy :: Arastehfar A; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA.
Daneshnia F; Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Hilmioglu-Polat S; Division of Mycology, University of Ege, Izmir, Turkey.
Ilkit M; Divison of Mycology, University of Çukurova, Adana, Turkey.
Yasar M; Division of Mycology, University of Ege, Izmir, Turkey.
Polat F; Division of Mycology, University of Ege, Izmir, Turkey.
Metin DY; Division of Mycology, University of Ege, Izmir, Turkey.
Dokumcu ÜZ; Department of Paediatric Surgery, Faculty of Medicine, University of Ege, Izmir, Turkey.
Pan W; Shanghai Key Laboratory Molecular Medical Mycology, Shanghai, China.
Hagen F; Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.; University Medical Center Utrecht, Utrecht, The Netherlands.
Boekhout T; Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.; Department of Paediatric Surgery, Faculty of Medicine, University of Ege, Izmir, Turkey.; Institute of Biodiversity and Ecosystems Dynamics (IBED), University of Amsterdam, Amsterdam, The Netherlands.
Perlin DS; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA.
Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 418-422.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Use of rilpivirine in HIV-1-infected individuals in routine clinical practice from 2012 to 2017 in France.
Autorzy :: Potard V; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.
Gallien S; AP-HP, Hôpital Henri Mondor, Service d'Immunologie et Maladies Infectieuses, Université Paris Est Créteil, Inserm U 955, Créteil, France.
Canestri A; AP-HP, Hôpital de Tenon, Service des Maladies Infectieuses et Tropicales, Paris, France.
Costagliola D; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.; Pokaż więcej
Corporate Authors :: French Hospital Database on HIV (FHDH-ANRS CO4)
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 467-476.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Treating COVID-19: are we missing out the window of opportunity?
Autorzy :: Sundararaj Stanleyraj J; Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.
Sethuraman N; Department of Microbiology, Apollo Hospitals, Chennai, India.
Gupta R; Department of Medicine, Kuwait Hospital, Sharjah, United Arab Emirates.
Thiruvoth S; Department of Infection Control, Kuwait Hospital, Sharjah, United Arab Emirates.
Gupta M; Department of Microbiology, Super Specialty Cancer Institute and Hospital, Lucknow, India.
Ryo A; Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 283-285.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study.
Autorzy :: Maillard A; Department of Infectious Diseases, St-Louis Hospital, APHP and University of Paris, France.
Scemla A; Kidney Transplant Unit, Hôpital Necker Enfants Malades, APHP and University of Paris, France.
Laffy B; Kidney Transplant Unit, Hôpital Saint-Louis, APHP and University of Paris, France.
Mahloul N; Medical Department, Sanofi-Aventis France, Gentilly, France.
Molina JM; Department of Infectious Diseases, St-Louis Hospital, APHP and University of Paris, France.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 487-494.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Co-occurrence of the blaVIM-1 and blaSHV-12 genes on an IncHI2 plasmid of an Escherichia coli isolate recovered from German livestock.
Autorzy :: Pauly N; Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Hammerl JA; Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Schwarz S; Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Grobbel M; Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Meemken D; Institute of Food Safety and Food Hygiene, Freie Universität Berlin, Berlin, Germany.
Malorny B; Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Tenhagen BA; Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Käsbohrer A; Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.; Unit for Veterinary Public Health and Epidemiology, University of Veterinary Medicine, Vienna, Austria.
Irrgang A; Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 531-533.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
Autorzy :: Palich R; Sorbonne University, Infectious Diseases department, Pitié-Salpêtrière hospital, AP-HP, Pierre Louis Epidemiology and Public Health institute (iPLESP), INSERM 1136, Paris, France.
Allavena C; Infectious Diseases department, University hospital, INSERM CIC 1413, Nantes, France.
Peytavin G; AP-HP, Pharmacology-Toxicology department, Bichat-Claude Bernard hospital, Paris, France.; INSERM, UMR1137, IAME, Université de Paris, Paris, France.
Soulie C; Sorbonne University, Virology department, Pitié-Salpêtrière hospital, AP-HP, Pierre Louis Epidemiology and Public Health institute (iPLESP), INSERM 1136, Paris, France.
Tubiana R; Sorbonne University, Infectious Diseases department, Pitié-Salpêtrière hospital, AP-HP, Pierre Louis Epidemiology and Public Health institute (iPLESP), INSERM 1136, Paris, France.
Weiss L; Paris Descartes University, Clinical Immunology department, Georges Pompidou hospital, AP-HP, INSERM 976, Paris, France.
Montoya Ferrer A; Infectious Diseases department, University hospital, Montpellier, France.
Duvivier C; University of Paris, Infectious Diseases department, Necker-Pasteur Infectiology Center, Necker hospital, AP-HP, INSERM 1016, IHU imagine, Paris, France.
Bouchaud O; Infectious Diseases department, Avicenne hospital, AP-HP, Paris, France.
Bottero J; Infectious Diseases department, Jean Verdier hospital, Paris, France.
Durand A; Sorbonne University, Pierre Louis Epidemiology and Public Health institute (iPLESP), INSERM 1136, Paris, France.
Lê MP; AP-HP, Pharmacology-Toxicology department, Bichat-Claude Bernard hospital, Paris, France.; INSERM, UMR_S 1144, Université de Paris, Paris, France.
Marcelin AG; AP-HP, Pharmacology-Toxicology department, Bichat-Claude Bernard hospital, Paris, France.
Dudoit Y; Sorbonne University, Infectious Diseases department, Pitié-Salpêtrière hospital, AP-HP, Pierre Louis Epidemiology and Public Health institute (iPLESP), INSERM 1136, Paris, France.
Assoumou L; Infectious Diseases department, Jean Verdier hospital, Paris, France.
Katlama C; Sorbonne University, Infectious Diseases department, Pitié-Salpêtrière hospital, AP-HP, Pierre Louis Epidemiology and Public Health institute (iPLESP), INSERM 1136, Paris, France.; Pokaż więcej
Corporate Authors :: ETRAL QD study group
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 477-481.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis.
Autorzy :: Oyardi Ö; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul University, 34116, Istanbul, Turkey.
Savage PB; Department of Chemistry and Biochemistry, Brigham Young University, 84602, Provo, UT, USA.
Erturan Z; Department of Medical Microbiology, Faculty of Medicine, Istanbul University, 34093, Istanbul, Turkey.
Bozkurt-Guzel C; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul University, 34116, Istanbul, Turkey.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 443-450.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
Autorzy :: Aulin LBS; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Koumans CIM; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Haakman Y; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
van Os W; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Kraakman MEM; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Gooskens J; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Smits WK; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Liakopoulos A; Institute of Biology, Leiden University, Leiden, The Netherlands.
van Hasselt JGC; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 533-535.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Reassessment of the cooperativity between efflux system MexAB-OprM and cephalosporinase AmpC in the resistance of Pseudomonas aeruginosa to β-lactams.
Autorzy :: Grosjean M; UMR6249 CNRS Chrono-Environnement, Université Bourgogne Franche-Comté, Besançon, France.; Smaltis, 2 rue Paul Milleret, 25000 Besançon, France.
Tazrout S; UMR6249 CNRS Chrono-Environnement, Université Bourgogne Franche-Comté, Besançon, France.
Bour M; Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Triponey P; Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Muller C; Smaltis, 2 rue Paul Milleret, 25000 Besançon, France.
Jeannot K; UMR6249 CNRS Chrono-Environnement, Université Bourgogne Franche-Comté, Besançon, France.; Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Plésiat P; UMR6249 CNRS Chrono-Environnement, Université Bourgogne Franche-Comté, Besançon, France.; Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de Besançon, Besançon, France.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 536-539.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Fluoroquinolone resistance in Achromobacter spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN.
Autorzy :: Magallon A; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.; UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.
Roussel M; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.
Neuwirth C; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.; UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.
Tetu J; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.; UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.
Cheiakh AC; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.
Boulet B; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.
Varin V; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.
Urbain V; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.
Bador J; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.; UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.
Amoureux L; Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France.; UMR/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comté, Besançon, France.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 297-304.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
Autorzy :: Salpini R; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Alkhatib M; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Costa G; Dipartimento di Scienze della Salute, Università 'Magna Græcia', Catanzaro, Italy.; Net4Science srl, Università 'Magna Græcia', Catanzaro, Italy.
Piermatteo L; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Ambrosio FA; Dipartimento di Scienze della Salute, Università 'Magna Græcia', Catanzaro, Italy.
Di Maio VC; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Scutari R; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Duca L; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Berno G; Laboratory of Virology, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Fabeni L; Laboratory of Virology, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Alcaro S; Dipartimento di Scienze della Salute, Università 'Magna Græcia', Catanzaro, Italy.; Net4Science srl, Università 'Magna Græcia', Catanzaro, Italy.
Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Artese A; Dipartimento di Scienze della Salute, Università 'Magna Græcia', Catanzaro, Italy.; Net4Science srl, Università 'Magna Græcia', Catanzaro, Italy.
Svicher V; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 396-412.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.
Autorzy :: Rosenke K; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Leventhal S; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Moulton HM; Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Hatlevig S; Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Hawman D; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Feldmann H; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Stein DA; Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jan 19; Vol. 76 (2), pp. 413-417.
Typ publikacji :: Journal Article; Research Support, N.I.H., Intramural
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] NLMUID: 7513617"" wg kryterium: JN

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Język